mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |